Martin-Orozco, Natalia
Vale, Noah
Mihic, Alan
Amor, Talya
Reiter, Lawrence
Arita, Yuko
Samson, Reuben
Hu, Queenie
Gingras, Anne-Claude
Sorenson, Bradley Thomas
Marcusson, Eric Gates
Patel, Piyush
Funding for this research was provided by:
National Research Council Canada
Canadian Institutes of Health Research
Article History
Received: 14 June 2022
Accepted: 22 May 2023
First Online: 26 May 2023
Competing interests
: N.M.O., L.R., Y.A., B.S., E.G.M., and P.P. are employees of PT. PT received funding for the Phase 1 trial from National Research Council of Canada. N.V., A.M., and T.A. work at Manna Research, the Contract Research Organization that performed the clinical trial. A-C.G., R.S., and Q.H. declare no potential conflict of interest. The development of the B.1.617.2 (Delta) lentiviral assay was supported by the CIHR operating grant to the Coronavirus Variants Rapid Response Network (CoVaRR-Net) to A-C.G. A-C.G. is the Canada Research Chair, Tier 1, in Functional Proteomics. All other authors have no competing interests.